Clinical trial
KL₄Surfactant Treatment in Patients With ARDS
NCT00215553 · Windtree Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00215553 |
|---|---|
| Title | KL₄Surfactant Treatment in Patients With ARDS |
| Official title | A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of SURFAXIN® (Lucinactant) Delivered Via Bronchopulmonary Segmental Lavage to Standard of Care in Patients With Acute Respiratory Distress Syndrome (ARDS). |
| Lead sponsor | Windtree Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Respiratory Distress Syndrome |
| Intervention type | Drug, Other |
| Interventions | A.1 Lucinactant, B.3 SoC, A.2 Lucinactant, A.3 Lucinactant, A.4 Lucinactant, B.1 Lucinactant, B.2 Lucinactant |
| Enrollment | 124 |
| Start date | May 1, 2001 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: